{"transactions":[{"id":1627907,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option Grant (Right to Buy)","published_at":"2024-02-22T02:38:15.000Z","date":"2024-02-16","kind":"grant","planned":false,"acquired":true,"shares":205213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was granted pursuant to the 2021 Plan. The shares underlying such option will vest in equal quarterly installments during 2024 such that 25% of the option will vest on each of March 31, 2024, June 30, 2024, September 30, 2024 and December 31, 2024, subject to the Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":205213,"derivative":{"exercise_price":0.434,"expiration_date":"2034-02-15","underlying":"Class A Common Stock","underlying_shares":205213},"source":{"system":"sec-edgar","filing":"0001493152-24-007487","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224007487/ownership.xml","form_type":"4"}},{"id":1627906,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2024-02-22T02:38:15.000Z","date":"2024-02-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":52762,"price":0.434,"value":22898.708,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting and settlement of restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\") and does not represent a sale."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects shares underlying RSUs subject to vesting."}],"balance_after":1122238,"source":{"system":"sec-edgar","filing":"0001493152-24-007487","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000149315224007487/ownership.xml","form_type":"4"}},{"id":1826593,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2023-07-19T16:21:39.000Z","date":"2023-07-14","kind":"grant","planned":false,"acquired":true,"shares":875000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A Common Stock. The RSUs are subject to (i) time-based vesting over a three-year period, with 25% vesting on the one-year anniversary of the grant date, 25% vesting on the two-year anniversary of the grant date, and the remainder vesting on the three-year anniversary of the grant date, and (ii) performance-based vesting based on the Issuer's stock price, and in each case subject to the Reporting Person's continuous service on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects shares underlying RSUs subject to vesting."}],"balance_after":1175000,"source":{"system":"sec-edgar","filing":"0000950170-23-033475","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000095017023033475/ownership.xml","form_type":"4"}},{"id":1998448,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Class A Common Stock","published_at":"2023-02-23T02:18:59.000Z","date":"2023-02-17","kind":"grant","acquired":true,"shares":300000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock.  The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":300000,"source":{"system":"sec-edgar","filing":"0000899243-23-005916","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000089924323005916/doc4.xml","form_type":"4"}},{"id":2143558,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:10:19.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":66226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Issuer's 2021 Equity Incentive Plan.  The shares underlying such option vest and become exercisable as follows: 25% on the one-year anniversary of the grant date, with the remainder vesting monthly thereafter so that it will be vested in full on the four-year anniversary of the grant date, subject to the Reporting Person's continuous service with the Issuer through each such date."}],"balance_after":66226,"derivative":{"exercise_price":2.19,"expiration_date":"2032-10-03","underlying":"Class A Common Stock","underlying_shares":66226},"source":{"system":"sec-edgar","filing":"0000899243-22-032650","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1752828/000089924322032650/doc4.xml","form_type":"4"}},{"id":2200074,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-29T18:31:04.000Z","date":"2022-07-27","kind":"grant","acquired":true,"shares":537164,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in two equal installments on the first and second anniversaries of the grant date."}],"balance_after":537164,"derivative":{"exercise_price":0.38,"exercise_date":"2023-07-27","expiration_date":"2032-07-26","underlying":"Common Stock","underlying_shares":537164},"source":{"system":"sec-edgar","filing":"0001214659-22-009391","document":"marketforms-56759.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293310/000121465922009391/marketforms-56759.xml","form_type":"4"}},{"id":2335280,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-14T16:37:16.000Z","date":"2022-03-09","kind":"purchase","acquired":true,"shares":5000,"price":2.78,"value":13900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.75 to $2.80, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001214659-22-003919","document":"marketforms-55788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1293310/000121465922003919/marketforms-55788.xml","form_type":"4"}},{"id":2335279,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-03-14T16:37:16.000Z","date":"2022-03-08","kind":"purchase","acquired":true,"shares":7000,"price":2.53,"value":17710.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.52 to $2.53, inclusive. The reporting person undertakes to provide upon request to the issuer, the Securities and Exchange Commission or any security holder of the issuer full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001214659-22-003919","document":"marketforms-55788.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293310/000121465922003919/marketforms-55788.xml","form_type":"4"}},{"id":2434759,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-14T17:05:24.000Z","date":"2022-01-12","kind":"grant","acquired":true,"shares":38411,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The stock option was granted to the Reporting Person at the direction of the Company in satisfaction of amounts earned under the Company's 2021 annual incentive plan."}],"balance_after":38411,"derivative":{"exercise_price":2.99,"exercise_date":"2023-01-12","expiration_date":"2032-01-11","underlying":"Common Stock","underlying_shares":38411},"source":{"system":"sec-edgar","filing":"0001214659-22-000733","document":"marketforms-55062.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293310/000121465922000733/marketforms-55062.xml","form_type":"4"}},{"id":2448399,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-04T18:20:25.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":34500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 ratable quarterly installments commencing March 31, 2022."}],"balance_after":34500,"derivative":{"exercise_price":3.72,"exercise_date":"2022-03-31","expiration_date":"2031-12-30","underlying":"Common Stock","underlying_shares":34500},"source":{"system":"sec-edgar","filing":"0001214659-22-000266","document":"marketforms-54936.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293310/000121465922000266/marketforms-54936.xml","form_type":"4"}},{"id":2494098,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-26T17:15:19.000Z","date":"2021-11-23","kind":"disposition_to_issuer","acquired":false,"shares":5863,"price":4.53,"value":26559.39,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"As reported in a Form 8-K filed by Humanigen, Inc. (the \"Company\") on November 26, 2021, with the approval of the compensation committee of the board of directors of the Company, the reporting person accepted the Company's offer to rescind his participation in the program pursuant to which the reporting person had agreed to receive stock options in lieu of 25% of his base salary for the fourth quarter of 2021, or $26,546. As a result, the stock option granted to the reporting person on September 30, 2021 was cancelled, and the reporting person will receive 100% of his base salary for the fourth quarter of 2021 in cash. The amount shown in column 8 equals the fair value of the option on the grant date of September 30, 2021 as calculated using the Black-Scholes options pricing model."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As reported in a Form 8-K filed by Humanigen, Inc. (the \"Company\") on November 26, 2021, with the approval of the compensation committee of the board of directors of the Company, the reporting person accepted the Company's offer to rescind his participation in the program pursuant to which the reporting person had agreed to receive stock options in lieu of 25% of his base salary for the fourth quarter of 2021, or $26,546. As a result, the stock option granted to the reporting person on September 30, 2021 was cancelled, and the reporting person will receive 100% of his base salary for the fourth quarter of 2021 in cash. The amount shown in column 8 equals the fair value of the option on the grant date of September 30, 2021 as calculated using the Black-Scholes options pricing model."}],"balance_after":0,"derivative":{"exercise_price":5.93,"exercise_date":"2021-10-31","expiration_date":"2031-09-30","underlying":"Common Stock","underlying_shares":5863},"source":{"system":"sec-edgar","filing":"0001214659-21-012330","document":"marketforms-54402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293310/000121465921012330/marketforms-54402.xml","form_type":"4"}},{"id":2551681,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-04T20:05:51.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":5863,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option was granted to the reporting person in lieu of 25% of his base salary for the fourth quarter of 2021. The option vests in three ratable installments on each of October 31, 2021, November 30, 2021 and December 31, 2021."}],"balance_after":5863,"derivative":{"exercise_price":5.93,"exercise_date":"2021-10-31","expiration_date":"2031-09-30","underlying":"Common Stock","underlying_shares":5863},"source":{"system":"sec-edgar","filing":"0001214659-21-010213","document":"marketforms-53962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293310/000121465921010213/marketforms-53962.xml","form_type":"4"}},{"id":2741832,"issuer":{"id":108862,"kind":"organization","name":"HUMANIGEN, INC","symbol":"HGEN"},"owners":[{"id":94038,"kind":"person","name":"Kilcoyne Adrian","position":1,"cik":"0001857963","reported_name":"Kilcoyne Adrian","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-22T16:44:44.000Z","date":"2021-04-21","kind":"grant","acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 12 ratable quarterly installments commencing September 30, 2021."}],"balance_after":155000,"derivative":{"exercise_price":14.99,"exercise_date":"2021-09-30","expiration_date":"2031-04-20","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001214659-21-004393","document":"marketforms-52317.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1293310/000121465921004393/marketforms-52317.xml","form_type":"4"}}]}